| Year |
Citation |
Score |
| 2020 |
Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC, Bhargava S, Lee D, King BH, Morton AR, Gimple RC, Pekmezci M, Zhu Z, Siqueira-Neto JL, Wang X, ... ... Chen C, et al. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Cancer Discovery. PMID 32703768 DOI: 10.1158/2159-8290.Cd-20-0160 |
0.348 |
|
| 2019 |
Cloughesy T, Petrecca K, Walbert T, Butowski N, Salacz M, Perry J, Damek D, Bota D, Bettegowda C, Zhu J, Iwamoto F, Placantonakis D, Martinez N, Elder JB, Kaptain G, ... ... Chen C, et al. LTBK-08. TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA Neuro-Oncology. 21: vi284-vi284. DOI: 10.1093/Neuonc/Noz219.1199 |
0.332 |
|
| 2019 |
Ferreira C, Alaei P, Chen C, Reynolds M, Sterling D, Dusenbery K. RTHP-32. FIRST EXPERIENCE WITH GAMMATILE PERMANENT IMPLANTS FOR RECURRENT BRAIN TUMORS Neuro-Oncology. 21: vi216-vi216. DOI: 10.1093/Neuonc/Noz175.903 |
0.346 |
|
| 2019 |
Koga T, Chaim I, Markmiller S, Benitez J, Parisian A, Miki S, Hessenauer F, Turner K, Venneti S, Malicki D, Wechsler-Reya R, Mischel P, Chen C, Yeo G, Furnari F. TMOD-28. AUTHENTIC HUMAN GLIOMA MODELING USING GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS Neuro-Oncology. 21: vi268-vi269. DOI: 10.1093/Neuonc/Noz175.1127 |
0.336 |
|
| 2019 |
Aiken R, Chen C, Cloughesy T, Colman H, Daras M, Groves M, Khagi S, Kumthekar P, Lang F, Nassiri F, Ong S, Ramakrishna R, Sonabend A, Vogelbaum M, Zadeh G, et al. ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192) Neuro-Oncology. 21: vi8-vi9. DOI: 10.1093/Neuonc/Noz175.032 |
0.315 |
|
| 2019 |
Mulford KL, Chen C, Dusenbery K, Yuan J, Hunt M, Chen C, Sperduto P, Watanabe Y, Wilke C. Tumor Cavity Shape Characteristics Do Not Predict Local Control in Patients with Resected Brain Metastases Receiving Adjuvant SRS International Journal of Radiation Oncology Biology Physics. 103. DOI: 10.1016/S0360-3016(19)30501-2 |
0.341 |
|
| 2018 |
Joshi R, Alattar A, Carroll K, Chen C. Path-03. Prognostic Importance Of Tumor Grade In The Post-Genomic Era Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.659 |
0.301 |
|
| 2017 |
Cloughesy TF, Ostertag D, Landolfi JC, Walbert T, Vogelbaum MA, Elder JB, Bloomfield S, Carter B, Chen C, Kalkanis SN, Kesari S, Lai A, Lee I, Liau LM, Mikkelsen T, et al. Durable complete responses observed in IDH1 mutated high grade glioma at first recurrence undergoing treatment with Toca 511 and Toca FC. Journal of Clinical Oncology. 35: e13504-e13504. DOI: 10.1200/Jco.2017.35.15_Suppl.E13504 |
0.36 |
|
| 2017 |
Joshi R, Hirshman B, Ali MA, Carroll K, Wilson B, Proudfoot J, Serizawa T, Yamamoto M, Nagano O, Aiyama H, Carter B, Chen C. CMET-45. USING CUMULATIVE INTRACRANIAL TUMOR VOLUME AS A PROGNOSTIC FACTOR IN THE GI-SPECIFIC GRADED PROGNOSTIC ASSESSMENT (GPA) MODEL Neuro-Oncology. 19: vi48-vi49. DOI: 10.1093/Neuonc/Nox168.191 |
0.31 |
|
| 2017 |
Cloughesy T, Landolfi J, Vogelbaum M, Ostertag D, Elder B, Carter B, Chen C, Kalkanis S, Lai A, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W, Diago O, Hogan D, et al. ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 & TOCA FC TREATMENT Neuro-Oncology. 19: vi26-vi26. DOI: 10.1093/Neuonc/Nox168.099 |
0.359 |
|
| 2017 |
Li J, Kaneda M, Patel K, Wang J, Akers J, Ramakrishnan V, Jiang T, Carter B, Varner J, Chen C. OS06.7 PI-3Kγ inhibition suppresses glioblastoma tumorigenicity through disruption of an IL11-STAT3-MYC signaling axis between microglia and glioblastoma Neuro-Oncology. 19: iii12-iii12. DOI: 10.1093/Neuonc/Nox036.041 |
0.304 |
|
| 2016 |
Cloughesy TF, Aghi MK, Chen C, Elder JB, Kesari S, Kalkanis SN, Kaptain G, Landolfi JC, Mikkelsen T, Portnow J, Robbins JM, Ostertag D, Das A, Chu A, Vogelbaum MA. Encouraging survival with Toca 511 and Toca FC compared to external lomustine control. Journal of Clinical Oncology. 34: 2030-2030. DOI: 10.1200/Jco.2016.34.15_Suppl.2030 |
0.324 |
|
| 2016 |
Chen C, Hirshman B, Wilson B, Amaan M, Proudfoot J, Koiso T, Nagano O, Serizawa T, Yamamoto M. Rthp-25. Superior Prognostic Value Of Cumulative Intracranial Tumor Volume (Citv) Relative To Largest Intracranial Tumor Volume (Litv) For Stereotactic Radiosurgery Treated Brain Metastasis Patients Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.751 |
0.348 |
|
| 2015 |
Shen Y, Li J, Furnari FB, Desai A, Chen H, Chen C. Abstract 3478: A multi-orthogonal strategy for targeting EGFRvIII expressing glioblastomas Cancer Research. 75: 3478-3478. DOI: 10.1158/1538-7445.Am2015-3478 |
0.301 |
|
| 2015 |
Dong X, Hirshman B, Padwal J, Proudfoot J, Chen C. Surg-08Superior Efficacy Of Gross Total Resection In Anaplastic Astrocytoma Patients Relative To Glioblastoma Patients Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov235.08 |
0.304 |
|
| 2015 |
Chen C, Sloan A, Mohammadi A, Barnett G. Surg-07A Multi-Institutional Experience On Laser Thermal Ablation As Treatment For Corpus Callosal Glioblasotmas. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov235.07 |
0.332 |
|
| 2015 |
Steed T, Treiber J, Patel K, Carter B, Dale A, Chow L, Chen C. Nimg-09Quantification Of Glioblastoma Localization Reveals Associations With Genomic Subtypes And Subventricular Zone Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov225.09 |
0.345 |
|
| 2015 |
Ostertag D, Hogan D, Vogelbaum M, Kesari S, Kalkanis S, Mikkelsen T, Landolfi J, Elder JB, Chen C, Niethammer A, Chu A, Jolly D, Gruber H, Cloughesy T. GENO-30DISTINCT GENE EXPRESSION PROFILE THAT IS NOT A KNOWN SURVIVAL PREDICTOR IN TUMORS FROM LONG-TERM HIGH GRADE GLIOMA SURVIVORS TREATED WITH A RETROVIRAL REPLICATING VECTOR ENCODING YEAST CYTOSINE DEAMINASE Neuro-Oncology. 17: v98.2-v98. DOI: 10.1093/Neuonc/Nov215.30 |
0.366 |
|
| 2015 |
Kozono D, Li J, Sampetrean O, Gonda D, Kushwaha D, Merzon D, Nitta M, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, ... ... Chen C, et al. EPIG-02DYNAMIC EPIGENETIC MODULATION OF GLIOBLASTOMA TUMORIGENICITY BY INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) Neuro-Oncology. 17: v86.2-v86. DOI: 10.1093/Neuonc/Nov214.02 |
0.305 |
|
| 2015 |
Dong X, Alattar A, Padwal J, Brandel M, Carter B, Chen C. EPID-10GROSS TOTAL RESECTION IS NOT ASSOCIATED WITH IMPROVED OVERALL SURVIVAL RELATIVE TO SUBTOTAL RESECTION IN PATIENTS WITH OLIGODENDROGLIOMAS, ANAPLASTIC OLIGODENDROGLIOMAS, AND OLIGOASTROCYTOMAS Neuro-Oncology. 17: v80.2-v80. DOI: 10.1093/Neuonc/Nov213.10 |
0.356 |
|
| 2015 |
Dong X, Noorbakhsh A, Hirshman B, Zhou T, Tang J, Chang D, Carter B, Chen C. EPID-09IMPROVED SURVIVAL OF LOW-GRADE GLIOMA PATIENTS (1999-2010) DESPITE DECREASED UTILIZATION OF RADIATION THERAPY: A SEER-BASED ANALYSIS. Neuro-Oncology. 17: v80.1-v80. DOI: 10.1093/Neuonc/Nov213.09 |
0.327 |
|
| 2015 |
Chen C, Jiang T. Epid-08Isocitrate Dehydrogenase (Idh) Mutation And Methyl-Guanine Methyl Transferase (Mgmt) Promoter Methylation Status In Glioblastoma: Results Of A Prospective Molecular Glioblastoma Registry Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov213.08 |
0.336 |
|
| 2015 |
Marcus L, Marshall D, McCutcheon B, Gonda D, Goetsch S, Hattangadi J, Carter B, Yamamoto M, Chen C. Bmet-09Cumulative Intracranial Tumor Volume (Citv) Enhances The Prognostic Value Of The Lung-Specific-Graded Prognostic Assessment (Gpa) Model Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov208.09 |
0.311 |
|
| 2015 |
Lai G, Mahadevan A, Hackney D, Warnke P, Kasper E, Wong E, Carter B, Chen C. BMET-08DIAGNOSTIC ACCURACY OF PET, SPECT, AND ASL IN DIFFERENTIATING TUMOR RECURRENCE FROM NECROSIS IN CEREBRAL METASTASIS POST-STEREOTACTIC RADIOSURGERY Neuro-Oncology. 17: v46.3-v46. DOI: 10.1093/Neuonc/Nov208.08 |
0.331 |
|
| 2015 |
Marshall D, Marcus L, McCutcheon B, Goetsch S, Alksne J, Ott K, Carter B, Hattangadi J, Koiso T, Yamamoto M, Chen C. BMET-07SURVIVAL PATTERNS OF PATIENTS WITH CEREBRAL METASTASES WHO UNDERWENT MULTIPLE ROUNDS OF STEREOTACTIC RADIOSURGERY (SRS) Neuro-Oncology. 17: v46.2-v46. DOI: 10.1093/Neuonc/Nov208.07 |
0.358 |
|
| 2014 |
Marcus LP, McCutcheon BA, Noorbakhsh A, Parina RP, Gonda DD, Chen C, Chang DC, Carter BS. Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). Journal of Neurosurgery. 120: 1201-11. PMID 24605840 DOI: 10.3171/2014.1.Jns131264 |
0.303 |
|
| 2014 |
Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha D, Vandenberg S, Ramakrishnan V, Zhu S, Furnari F, Matsui H, Harismendy O, Cavenee W, Mao Y, et al. CB-04 * EPIGENETIC REGULATION OF GLIOBLASTOMA TUMORIGENICITY: A HYBRID MODEL Neuro-Oncology. 16: v41-v41. DOI: 10.1093/Neuonc/Nou241.4 |
0.308 |
|
| 2014 |
Chen C, Gonda D, Kim T, Goetsch S, Kawabe T, Watanabe S, Alksne J, Hattangadi J, Ott K, Hodgens D, Carter B, Yamamoto M. BM-08 * PROGNOSTIC FACTORS FOR SRS-TREATED PATIENTS WITH CEREBRAL METASTASIS: IMPLICATIONS ON RANDOMIZED CONTROL TRIAL DESIGN AND INTER-INSTITUTIONAL COLLABORATIVE EFFORTS Neuro-Oncology. 16: v33-v33. DOI: 10.1093/Neuonc/Nou240.8 |
0.35 |
|
| 2012 |
Pan H, Cerviño LI, Pawlicki T, Jiang SB, Alksne J, Detorie N, Russell M, Carter BS, Murphy KT, Mundt AJ, Chen C, Lawson JD. Frameless, real-time, surface imaging-guided radiosurgery: clinical outcomes for brain metastases. Neurosurgery. 71: 844-51. PMID 22989959 DOI: 10.1227/Neu.0B013E3182647Ad5 |
0.303 |
|
| 2012 |
Pertschuk D, Cloughesy TF, Chang SM, Aghi MK, Vogelbaum MA, Liau LM, Shafa BB, Yong WH, Chen C, Kesari S, Ibanez CE, Perez OD, Robbins JM, Jolly DJ, Gruber HE. Ascending dose trials of the safety and tolerability of Toca 511, a retroviral replicating vector encoding cytosine deaminase, in patients with recurrent high-grade glioma. Journal of Clinical Oncology. 30: 2101-2101. DOI: 10.1200/Jco.2012.30.15_Suppl.2101 |
0.338 |
|
| 2011 |
Mahadevan A, Floyd S, Wong E, Chen C, Kasper E. Clinical outcome after Hypofractionated Stereotactic Radiotherapy (HSRT) for benign skull base tumors Computer Aided Surgery. 16: 112-120. PMID 21466421 DOI: 10.3109/10929088.2011.565160 |
0.36 |
|
| 2011 |
Kozono D, Nitta M, Ng K, Zinn PO, Kushwaha D, Koay D, Merzon D, Zhu K, Zhu S, Ligon K, Chen C. Abstract 3301: c-Myc modulates the dynamic transition between tumor initiating states in glioblastoma Cancer Research. 71: 3301-3301. DOI: 10.1158/1538-7445.Am2011-3301 |
0.312 |
|
| Show low-probability matches. |